Nivolumab: an investigational agent for the treatment of biliary tract cancer

Expert Opinion on Investigational Drugs ◽

10.1080/13543784.2021.1863946 ◽

2020 ◽

pp. 1-8

Author(s):

Alessandro Di Federico ◽

Alessandro Rizzo ◽

Angela Dalia Ricci ◽

Giorgio Frega ◽

Andrea Palloni ◽

...

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Investigational Agent ◽

Download Full-text

Atezolizumab: an investigational agent for the treatment of biliary tract cancer

Expert Opinion on Investigational Drugs ◽

10.1080/13543784.2021.1974838 ◽

2021 ◽

Author(s):

Stephen P. Hack ◽

Andrew X. Zhu

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Investigational Agent ◽

Download Full-text

Chemotherapy for biliary tract cancer in Japan

Seminars in Oncology ◽

10.1053/sonc.2002.37377 ◽

2002 ◽

Vol 29 (6U) ◽

pp. 51-53 ◽

Author(s):

Takuji Okusaka

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Download Full-text

EGFR and HER2 Expression in advanced Biliary Tract Cancer

Zeitschrift für Gastroenterologie ◽

10.1055/s-0028-1089488 ◽

2008 ◽

Vol 46 (09) ◽

Author(s):

J Harder ◽

O Waiz ◽

M Geissler ◽

HE Blum ◽

A Schmitt-Gräff ◽

...

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Her2 Expression ◽

Download Full-text

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1551754 ◽

2015 ◽

Vol 53 (05) ◽

Author(s):

C Mayr ◽

A Wagner ◽

D Neureiter ◽

M Pichler ◽

M Ritter ◽

...

Keyword(s):

Cancer Cells ◽

Green Tea ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Epigallocatechin Gallate ◽

Tract Cancer ◽

Green Tea Catechin

Download Full-text

Prognostic value of early CA19-9 response during chemotherapy in patients with advanced or recurrent biliary tract cancer

10.26226/morressier.59a6b342d462b80290b53e8f ◽

2017 ◽

Author(s):

Naminatsu Takahara

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Prognostic Value ◽

Download Full-text

Orphan designation: (5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-β-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (etoposide toniribate), Treatment of biliary tract cancer

Case Medical Research ◽

10.31525/cmr-10e769a ◽

2019 ◽

Author(s):

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Orphan Designation ◽

Download Full-text

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Case Medical Research ◽

10.31525/ct1-nct03943043 ◽

2019 ◽

Author(s):

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Download Full-text

Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

Case Medical Research ◽

10.31525/ct1-nct04027764 ◽

2019 ◽

Author(s):

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Download Full-text

Faculty Opinions recommendation of Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995584.793475609 ◽

2013 ◽

Author(s):

Piero Portincasa ◽

Leonilde Bonfrate

Keyword(s):

Folinic Acid ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Hepatic Arterial Infusion ◽

Arterial Infusion ◽

Download Full-text

Faculty Opinions recommendation of A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737855899.793579682 ◽

2020 ◽

Author(s):

Mitesh Borad

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase 2 ◽

Download Full-text